Spotlight on Psoriasis
Showcasing the latest news and clinical breakthroughs in care, Spotlight on Psoriasis shines an educational beacon for healthcare professionals dedicated to improving patients’ quality of life and outcomes.
Here you’ll find leading dermatology specialists and other allied healthcare professionals sharing research updates and novel insights on collaborative, evidence-based practices to achieve skin clearance and optimize the treatment of patients with psoriasis.
1-15 of 45
Avery H. LaChance, MD, MPH, FAAD
Maria Gkini, MD, MSc, PhD
Personalizing Treatment in Moderate-to-Severe Psoriasis
DermConsultPersonalizing Treatment in Moderate-to-Severe Psoriasis
Eingun James Song, MD, FAAD, Co-CMO
The Future of Psoriasis Care: Novel Therapies and Earlier Intervention
DermConsultThe Future of Psoriasis Care: Novel Therapies and Earlier Intervention
Eingun James Song, MD, FAAD, Co-CMO
Rethinking Quality-of-Life Tools for Psoriasis Patients with Skin of Color
DermConsultRethinking Quality-of-Life Tools for Psoriasis Patients with Skin of Color
Megan R Hauptman, MD
How Can We Make Psoriasis Research More Equitable?
DermConsultHow Can We Make Psoriasis Research More Equitable?
Megan R Hauptman, MD
- advertisement
Validating hf-PGA for Hand and Foot Psoriasis Severity in Adults
DermConsultValidating hf-PGA for Hand and Foot Psoriasis Severity in Adults
IL-17A Inhibition and Neuroendocrine Signaling in Psoriasis
DermConsultIL-17A Inhibition and Neuroendocrine Signaling in Psoriasis
Ryan Quigley
IL-17A Inhibition and the Stress Response in Psoriasis
AudioAbstractsIL-17A Inhibition and the Stress Response in Psoriasis
Ryan Quigley
Addressing Diagnostic Gaps in Psoriasis for Skin of Color
DermConsultAddressing Diagnostic Gaps in Psoriasis for Skin of Color
Megan R Hauptman, MD
Key Factors That Influence Psoriasis Diagnosis and Management
DermConsultKey Factors That Influence Psoriasis Diagnosis and Management
Christopher Bunick, MD, PhD, FAAD
- advertisement
Exploring the Future of Psoriasis Treatment with Oral Agents
DermConsultExploring the Future of Psoriasis Treatment with Oral Agents
Christopher Bunick, MD, PhD, FAAD
Rethinking the Routine: Moving from Topicals to Systemics in Psoriasis
DermConsultRethinking the Routine: Moving from Topicals to Systemics in Psoriasis
Christopher Bunick, MD, PhD, FAAD
Rethinking Hepatotoxicity Risk in Oral Psoriasis Therapies
AudioAbstractsRethinking Hepatotoxicity Risk in Oral Psoriasis Therapies
Ryan Quigley
